Maitland AD

Designer Drug Research Unit, National Institute on Drug Abuse, Intramural Research Program, Baltimore, Maryland 21224, United States.

5 papers · 1 preprint · ORCID

ArticleDMT

Synthesis and Biological Evaluation of 4‑Bromo-<i>N,N-</i>dimethyltryptamine (4-Br-DMT): A Synthetic Building Block for Future Analog Development.

Bray E, Glatfelter GC, Maitland AD +5

Europe PMC2026
ArticlePsychedelics

Serotonin Transporter Blockade Reduces the Psychedelic-Like Effects of 4-Methoxy-<i>N</i>-methyl-<i>N</i>-isopropyltryptamine and Related Analogs.

Glatfelter GC, Schalk SS, Walther D +9

Europe PMC2026
PreprintPsilocybin

Serotonergic Polypharmacology of 2-Halogenated Tryptamines

Yacoub J, Bray E, Bayyat J +14

Europe PMC2026
ArticlePsychedelics

The 4-alkyl chain length of 2,5-dimethoxyamphetamines differentially affects in vitro serotonin receptor actions versus in vivo psychedelic-like effects.

Luethi D, Glatfelter GC, Pottie E +12

Europe PMC2026
Article5-MeO-DMT

Rapid, Open-Source, and Automated Quantification of the Head Twitch Response in C57BL/6J Mice Using DeepLabCut and Simple Behavioral Analysis.

Maitland AD, Gonzalez NR, Walther D +3

Europe PMC2025
ArticlePsilocybin

Psychedelic-like effects induced by 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, and psilocybin in male and female C57BL/6J mice.

McGriff SA, Hecker JC, Maitland AD +3

Europe PMC2025